to view your mail
U.S. markets closed
Should Facebook ban Trump forever?
Facebook's oversight board will soon decide Trump's fate.
COMPASS Pathways plc (CMPS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 4:00PM EST
297 reactions on $CMPS conversation
Sign in to post a message.
Back in at $41. GLTA!
Just got put on to this company today. Will be buying some this week.
I'm not a shareholder here as of yet. YET, but I do plan on loading up in the coming month. I recently latched onto the CMPS story because another company I follow religiously has entered the microdosing psychedelic space as well. What's even more so in common is both companies share your Chair of Scientific Advisory Board, Prof David Nutt DM FRCP FRCPSYCH FSB FMEDSCI. A couple of days ago, I had the pleasure of listening to Dr. Nutt speak alongside Algernon Pharmaceuticals CEO at the Psychedelic Capital Virtual Investment Conference. He's a brilliant speaker/thinker. I'm expecting BIG BIG things for both companies in the near term future.
Due Diligence read:
Good Luck 2 All @ CMPS
looks like it retested support at 49 and held. Will head even higher soon :)
CMPS may be expensive compared to the other Psych companies, but is far ahead. COMP360 will be approved faster than extracts. Legal microdosing has so many more applications than just depression... listen to Tim Ferriss, etc.
Yahoo Finance Insights
CMPS is up 11.88% to 50.48
Breakout confirmed! Good volume today, on our way to hit 60 first :)
proud holder of 42 shares. nice to finally be in.
Welp something lit a fire under Compass these last couple day. Holding long, and good to see the love.
will be up additional 20% after hours
CMPS is the bellwether for the whole sector as its FDA fast tracked. look for more institutional investment to confirm trend. given the low float and Nasdaq listing it's the best and safest play far more then MMED with it's horrible share structure. I also invest in PSYK and TRIP which is building awareness and a brand as well as a path to revenue.
This one is going to $200
One of the best trades I ever made was buying into a company known as Tweed a little known MJ company at the time, that later became Canopy Growth. I am now focused on getting into psychedelic companies before the rush is on. The further ahead a company moves in the approval process, the more valuable the company becomes, Compass Pathways (CMPS) is in Phase 2b trials and has received a "Breakthrough Therapy" designation from the FDA, meaning that their therapy has the potential to be more effective than available medications. It's important in this kind of investment to be mindful of the stage a company is in. The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine (MMEDF) , Cybin Inc. (CLXPF) , and Mydecine Innovations Group (MYCOF). I am currently holding positions in CMPS, MMEDF, CLXPF, LKYSF and TRUFF. As always, do your own research and make up your own mind. I use a category minded approach on an investment like this. I also tend to invest in steps and try to grab deals on dips as well as dump investments that underperform over time.
This company has legs! Stick with it.
10 yrs ...this will be the treatment for most mental health disorders.
why up so much today?
This is peanuts for what is to come
message for retail: it looks like someone is trying to push us out and make money doing at the same time. If I were you, I would hold. PT 200 (2-3 year hold). ST: 80-100 (6 months - 1 year, if your into that). I would post this on a rainy day but then I'd be a bag holder.
This is wonderful stock, could touch $100, strong buy rating.
To get the next stimulus check, you may need to hustle with your taxes
Breaking down how the pandemic has hurt working women
Yahoo Finance Video
Elon Musk trolls GM, Chrysler on Twitter. Ford CEO responds with 1 word.
Advertise with us
© 2021 Verizon Media. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research